Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

SIMPLE SUMMARY: Accurate and early selection of patients with advanced non-small-cell lung cancer (NSCLC) who would benefit from immunotherapy is of the utmost clinical importance. The aim of our retrospective multi-centric study was to determine the potential role of CT-based radiomics machine lear...

Descripción completa

Detalles Bibliográficos
Autores principales: Cousin, François, Louis, Thomas, Dheur, Sophie, Aboubakar, Frank, Ghaye, Benoit, Occhipinti, Mariaelena, Vos, Wim, Bottari, Fabio, Paulus, Astrid, Sibille, Anne, Vaillant, Frédérique, Duysinx, Bernard, Guiot, Julien, Hustinx, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093736/
https://www.ncbi.nlm.nih.gov/pubmed/37046629
http://dx.doi.org/10.3390/cancers15071968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093736/
https://www.ncbi.nlm.nih.gov/pubmed/37046629
http://dx.doi.org/10.3390/cancers15071968

Ejemplares similares